Fundraising FoxEIR Ventures — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
GutCRINEgutcrine.dkApr 2023
Gutcrine is a Danish biotech developing pharmabiotics derived from gut microbiome hormone synthesis, aimed at the prevention and treatment of cardio-metabolic disorders.
BiotechDeep TechHealthtechLongevityCopenhagen, DK
Oluf Pedersen(CSO & Co-founder)Yong Fan(COO & Co-founder)Tobias Horneman-Thielcke(CEO)in
Hoba Therapeutics ApShobatherapeutics.comDec 2023
Danish biotech developing non-opioid restorative treatments for chronic pain, hearing loss and sensory neuron disorders.
Co-investorsIndaco Venture PartnersMedical Incubator Japan K.K.Novo Holdings
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.